top of page

Colo-205 Xenograft Model

Rincon Bio offers efficacy studies using the Colo-205 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Colon
ATCC link (if available):
Derivation:
Ascites of a 70yo male with colon carcinoma after 5FU treatment, the same patient as used to develop the COLO 201 line
Mutations:
APC, BRAF, CTNNB1, TP53
NCI60:
Yes
Weeks from stratification to termination (average):
2.5

Colo-205 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the Colo-205 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page